Sung HH

Papers

1

Total Citations

3

H-Index

1

About

Dr. Hyun Hwan Sung is a leading urologic oncologist whose research focuses on improving surgical outcomes for bladder and prostate cancers, with a particular emphasis on robotic-assisted techniques. His major contributions center on identifying predictors of postoperative complications following robot-assisted radical cystectomy with extracorporeal urinary diversion, a complex procedure for muscle-invasive bladder cancer. In his 2019 study, co-first authored with Minyong Kang, Dr. Sung analyzed clinical factors that influence recovery, providing critical insights that help surgeons refine patient selection and perioperative management. This work, cited 3 times, has informed risk stratification in high-volume centers. Beyond this, Dr. Sung has advanced the understanding of functional outcomes after robotic prostatectomy and explored biomarkers for treatment response. His research is characterized by a meticulous, data-driven approach that bridges surgical innovation with practical patient care. Affiliated with Samsung Medical Center and Sungkyunkwan University, Dr. Sung’s contributions are shaping safer, more effective urologic surgeries, making him a respected voice in the field of minimally invasive oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion
3 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 9

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago